Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.
about
Cardiovascular gene therapy for myocardial infarctionNovel therapy for myocardial infarction: can HGF/Met be beneficial?A visible, targeted high-efficiency gene delivery and transfection strategyQuantitative MR measurements of regional and global left ventricular function and strain after intramyocardial transfer of VM202 into infarcted swine myocardiumMR assessment of myocardial perfusion, viability, and function after intramyocardial transfer of VM202, a new plasmid human hepatocyte growth factor in ischemic swine myocardium.Silent disease progression in clinically stable heart failure.Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actionsCatheter-based intramyocardial delivery (NavX) of adenovirus achieves safe and accurate gene transfer in pigs.Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs.Cardiovascular magnetic resonance imaging in delivering and evaluating the efficacy of hepatocyte growth factor gene in chronic infarct scarSerum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's Disease.Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism.Percutaneous nonviral delivery of hepatocyte growth factor in an osteotomy gap promotes bone repair in rabbits: a preliminary study.VEGFR and type-V RTK activation and signalingModification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agentsHuman studies of angiogenic gene therapy.Non-viral gene therapy for myocardial engineering.Cardiac gene therapy in large animals: bridge from bench to bedside.Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.The emerging role of hepatocyte growth factor in renal diseases.Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes.Long-term effects of hepatocyte growth factor gene therapy in rat myocardial infarct model.Treatment of chronical myocardial ischemia by adenovirus-mediated hepatocyte growth factor gene transfer in minipigs.Effects of anti-aggregant, anti-inflammatory and anti-coagulant drug consumption on the preparation and therapeutic potential of plasma rich in growth factors (PRGF).Hepatocyte growth factor is associated with progression of atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA).Recruitment of stem cells by hepatocyte growth factor via intracoronary gene transfection in the postinfarction heart failure.HGF/Met Axis in Heart Function and Cardioprotection.Gene-Therapeutic Strategies Targeting Angiogenesis in Peripheral Artery Disease.
P2860
Q27014770-3939C88C-A9B3-42C4-8A83-3BE69314C033Q28305555-B2416A1E-A77B-4CB0-B128-EA83838D59C7Q30475161-72BD41D8-5F19-4803-9C25-826193D00FC9Q30487688-E39E8ADB-715C-4D71-A192-C175F067EAF4Q33557290-C73EC877-BAE2-4F47-A814-74021BC8D0A0Q33578212-C368E457-8E90-4B38-9A2F-55C42B509ED5Q33699411-0A33F784-4A80-4BB4-96D1-815289A39064Q34542255-B99B1104-C2AA-4E34-8544-7A36B308F3F9Q34784692-83E930E4-607F-49CF-996F-8F54DF85DE19Q36053983-002ACEF6-5346-41E6-9AB1-D21AEEA875D4Q36257471-CE6317A9-A58D-4197-A3E1-C02625423D9FQ36961089-BA0C8F4C-DEFE-4BDB-BADD-D6E27105818CQ37065913-F75A69B6-DA41-4CF7-8BA3-57E8590C0ABBQ37197494-50E02F6A-6254-475C-BF09-972EE089E06DQ37295564-E87F8F25-10C7-4452-A4B6-5E363037008DQ37406656-D53CE959-4AC7-444C-AB4C-0FCE76BCF84FQ37671758-372516B9-7970-424D-A6BD-2EDA0E27C23EQ37981008-213F5A25-71BC-4FED-92A0-C3F3824A8663Q38132253-E3C42F2E-9C41-42C3-8948-42FFD115D3B7Q38605788-0C93F46E-57C8-44EE-B36B-D3DC41B3CAA7Q40089884-6708790C-A8A6-49B6-B7A7-6E5BA5276A72Q45873331-358745C8-A404-48D6-A963-5C6D9546E5ECQ45877656-57681C29-58EE-49A6-B2B4-89304B30FAC5Q48818751-902DDF36-8ACE-41B9-AA31-28544E08B100Q52612811-52039F44-93C5-43A3-BBF1-160BDEF8E3D7Q53519045-57272A39-47E6-44C9-8802-40DE53ACB88AQ54256769-BB31FF20-0225-4FE5-8F6A-177B605660F2Q55452882-FEDF1A60-52B4-48D8-98FB-7C57A46766EE
P2860
Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Angiogenic and antifibrotic ac ...... rcine ischemic cardiomyopathy.
@ast
Angiogenic and antifibrotic ac ...... rcine ischemic cardiomyopathy.
@en
Angiogenic and antifibrotic ac ...... rcine ischemic cardiomyopathy.
@nl
type
label
Angiogenic and antifibrotic ac ...... rcine ischemic cardiomyopathy.
@ast
Angiogenic and antifibrotic ac ...... rcine ischemic cardiomyopathy.
@en
Angiogenic and antifibrotic ac ...... rcine ischemic cardiomyopathy.
@nl
prefLabel
Angiogenic and antifibrotic ac ...... rcine ischemic cardiomyopathy.
@ast
Angiogenic and antifibrotic ac ...... rcine ischemic cardiomyopathy.
@en
Angiogenic and antifibrotic ac ...... rcine ischemic cardiomyopathy.
@nl
P2093
P2860
P356
P1433
P1476
Angiogenic and antifibrotic ac ...... orcine ischemic cardiomyopathy
@en
P2093
Morishita R
Nakamura T
Taniyama Y
P2860
P2888
P304
P356
10.1038/SJ.GT.3302740
P577
2006-04-20T00:00:00Z